微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 4.31% | 6.95% | -72.69% | 15/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 15.78% | 16.72% | 29.98% | 5/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 12.14% | 14.85% | 63.17% | 9/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 7.44% | 17.35% | 84.62% | 12/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 4.03% | 24% | -70.19% | 14/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 13.52% | 29.25% | 27.91% | 9/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 10.57% | 40% | 66.72% | 16/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 6.34% | 35.47% | 95.08% | 18/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.25% | 47.06% | -68.93% | 23/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 10.46% | 51.81% | 38.54% | 22/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 7.55% | 47.46% | 61.32% | 27/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 4.68% | 73.98% | 111.76% | 34/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 2.21% | 92.17% | -67.92% | 41/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 6.89% | 93.54% | 34.57% | 37/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 5.12% | 68.98% | 90.33% | 42/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 2.69% | 144.55% | 133.91% | 47/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.15% | 82.54% | -67.7% | 49/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 3.56% | 990% | 17.49% | 49/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 3.03% | 1542.86% | 175.45% | 56/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 1.1% | 202.8% | 74.6% | 59/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.63% | 179.75% | 257.5% | 59/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -0.4% | 91.98% | -90.48% | 62/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | -0.21% | -111.17% | 80.37% | 63/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | -1.07% | -181.68% | -35.44% | 61/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | -0.79% | -123.1% | 84.17% | 62/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | -4.99% | -127.55% | -365.43% | 61/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 1.88% | -84.41% | 43.51% | 57/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 1.31% | -83.23% | -61.7% | 56/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 3.42% | -43% | -81.12% | 21/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 18.11% | -15.92% | 50.17% | 8/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 12.06% | -16.02% | 54.42% | 10/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 7.81% | -20.79% | 30.17% | 11/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 6% | -14.04% | -72.14% | 3/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 21.54% | -4.77% | 50% | 5/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 14.36% | -13.81% | 45.64% | 5/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 9.86% | -7.85% | 41.26% | 4/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 6.98% | -6.56% | -69.14% | 2/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 22.62% | -0.92% | 35.77% | 5/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 16.66% | -8.31% | 55.7% | 4/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 10.7% | -6.71% | 43.24% | 3/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 7.47% | -12.22% | -67.28% | 4/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |